Revance Therapeutics, Inc.
) was a big mover last session, as its shares rose nearly 26% on
the day. The move came on solid volume too with far more shares
changing hands than in a normal session. This breaks the trend for
the company as the stock is now trading above the volatile price
range of $26.16 to $33.70 in the past one-month timeframe.
In the last 30-day frame, the company did not witness any estimate
revision and the Zacks Consensus Estimate hasn't been in a trend
either. Yesterday's price action is encouraging though, so make
sure to keep a close watch on this firm in the near future.
Revance Therapeutics currently has a Zacks Rank #3 (Hold) while its
Other better-ranked stocks in the medical sector include
ZIOPHARM Oncology, Inc.
Biogen Idec Inc.
). All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download
7 Best Stocks for the Next 30 Days
Click to get this free report >>
BIOGEN IDEC INC (BIIB): Free Stock Analysis
REVANCE THERAP (RVNC): Free Stock Analysis
TROVAGENE INC (TROV): Get Free Report
ZIOPHARM ONCLGY (ZIOP): Free Stock Analysis
To read this article on Zacks.com click here.